2022 American Transplant Congress Archives - Page 15 of 190

5:30pm-7:00pm: High KDPI Kidneys: Lifelong Freedom from Dialysis for Elderly Patients

M. M. Romine¹, W. Irish², H. Jones³, A. Aaron², D. Leeser⁴

Kidney Deceased Donor Selection • Hynes Halls C & D

5:30pm-7:00pm: High Pretransplant FGF-23 Level is Associated with Poor Graft Survival and Persistent Vitamin D Insufficiency in Kidney Transplant Patients

J. Ryu¹, H. Jeon², T. Koo³, J. Yang⁴

Kidney: Cardiovascular and Metabolic Complications • Hynes Halls C & D

5:30pm-7:00pm: Higher Proinflammatory Cytokines Are Associated with Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients

A. H. Karaba¹, X. Zhu¹, S. E. Benner¹, O. Akinde¹, Y. Eby¹, K. H. Wang¹, S. Saraf², J. M. Garonzik-Wang³, S. L. Klein¹, J. R. Bailey¹, A. L. Cox¹, J. N. Blankson¹, C. M. Durand¹, D. L. Segev¹, W. A. Werbel¹, A. A. Tobian¹

All Infections (Excluding Kidney & Viral Hepatitis) I • Hynes Halls C & D

5:30pm-7:00pm: Histologic Predictors of Graft Loss in Early Clinically Indicated Biopsies After Kidney Transplantation

M. Ajaimy¹, V. Hemmige², L. E. Liriano-Ward³, Y. Azzi¹, S. Kapoor⁴, P. Loarte¹, C. Pynadath⁵, A. Colovai¹, E. Akalin⁶

Kidney Complications: Immune Mediated Late Graft Failure • Hynes Halls C & D

5:30pm-7:00pm: HLA-II Subclasses Behave Differently Between Themselves and Between Humans: Cues to Understand Alloreactivity

S. Beland, O. Desy, M. Marcoux, M. Thivierge, J. Desgagnes, S. A. De Serres

Chronic Organ Rejection • Hynes Halls C & D

5:30pm-7:00pm: Immunogenicity of a 3rd Dose of Mrna Covid-19 Vaccine in Kidney Transplant Recipients Who Failed to Respond to 2 Prior Doses

W. Werbel¹, A. Karaba¹, T. Chiang¹, T. Liang¹, A. Massie¹, M. Bettinotti¹, W. Clarke¹, N. Watson², A. Tobian¹, C. Durand¹, N. Bridges², D. Rostrosen², C. Larsen³, P. Heeger⁴, D. Segev¹

All Infections (Excluding Kidney & Viral Hepatitis) I • Hynes Halls C & D

5:30pm-7:00pm: Immunosuppressant Medications Use in Patients with Transplant Failure: A Canadian Multi-Centre Prospective Study

G. Knoll¹, M. Chassé², D. Fergusson³, A. A. House⁴, O. Johnston⁵, R. Mainra⁶, D. Baran⁷, D. Treleaven⁸, l. senecal⁹, L. Tibbles¹⁰, M. Hebert¹¹, M. Karpinski¹², T. Campbell¹³, T. Ramsay¹⁴, J. Kim¹⁵, I. Houde¹⁶, C. White¹⁷, J. Perl¹⁵, P. Karnabi¹⁸, J. Gill⁵

Kidney: Cardiovascular and Metabolic Complications • Hynes Halls C & D

5:30pm-7:00pm: Impact of Belatacept Conversion on Renal Function and Donor Specific Antibodies in Renal Transplant Recipients

E. R. Brown, K. Cunningham, K. Paplaczyk, C. Dagostino, C. Kane, A. Shetty

Kidney Complications: Immune Mediated Late Graft Failure • Hynes Halls C & D

5:30pm-7:00pm: Impact of Cold Ischemia Times on 1 Year Kidney Transplant Outcomes

T. Fletchinger, L. Burdine

Kidney Deceased Donor Selection • Hynes Halls C & D

5:30pm-7:00pm: Impact of Delayed Graft Function in Donation After Circulatory Death Kidney Transplantation

J. Mello Offerni¹, H. Brar¹, D. Lee¹, M. Levine², M. Mandurah¹, S. Rim¹, A. Sener¹, P. Luke¹

Kidney Deceased Donor Selection • Hynes Halls C & D